Array-Based Comparative Genomic Hybridization Characterizes a Deletion Associated With a t(15;17) in Acute Promyelocytic Leukemia

被引:6
作者
Dolan, Michelle [1 ]
Peterson, Bruce [2 ]
Hirsch, Betsy [1 ]
机构
[1] Univ Minnesota, Sch Med, Cytogenet Lab, Dept Lab Med, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Dept Pathol & Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA
关键词
Clinical pathology; Hematopathology; Genetics;
D O I
10.1309/AJCPENMUI47OGKRW
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The majority of de novo leukemias are characterized by well-known recurring translocations or inversions. In approximately 2% to 20% of these cases, deletions accompany these rearrangements. Because such deletions are undetectable by G-banding, aberrant fluorescence in situ hybridization (FISH) signal patterns are often the only indication of their presence. Array-based comparative genomic hybridization (a-CGH) permits examination of the entire genome at a resolution unattainable by G-banding or FISH. We present a case of a deletion of the derivative chromosome 17 of a t(15;17) in acute promyelocytic leukemia, the size and gene content Of which were characterized by a-CGH. We hypothesize that this patient's more aggressive disease course is due to loss of one or more of these genes. Such submicroscopic deletions involving the t(15;17) have only rarely been reported, and, to our knowledge, this is the first case in which a-CGH has been applied to its characterization.
引用
收藏
页码:818 / 823
页数:6
相关论文
共 34 条
[1]  
[Anonymous], 2005, ISCN (2005): An International System for Human Nomenclature
[2]  
Bacher U, 2005, HAEMATOLOGICA, V90, P558
[3]   Human replication protein Cdc6 prevents mitosis through a checkpoint mechanism that implicates Chk1 [J].
Clay-Farrace, L ;
Pelizon, C ;
Santamaria, D ;
Pines, J ;
Laskey, RA .
EMBO JOURNAL, 2003, 22 (03) :704-712
[4]   A HUMAN C-ERBA ONCOGENE HOMOLOG IS CLOSELY PROXIMAL TO THE CHROMOSOME 17 BREAKPOINT IN ACUTE PROMYELOCYTIC LEUKEMIA [J].
DAYTON, AI ;
SELDEN, JR ;
LAWS, G ;
DORNEY, DJ ;
FINAN, J ;
TRIPPUTI, P ;
EMANUEL, BS ;
ROVERA, G ;
NOWELL, PC ;
CROCE, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (14) :4495-4499
[5]   Clinical implications of der(9q) deletions detected through dual-fusion fluorescence in situ hybridization in patients with chronic myeloid leukemia [J].
de Campos, Mireille Guimaraes Vaz ;
Tadeu Montesano, Fabio ;
Madalena Rodrigues, Maria ;
Ferrari Chauffaille, Maria de Lourdes Lopes .
CANCER GENETICS AND CYTOGENETICS, 2007, 178 (01) :49-56
[6]   Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy [J].
Dewald, GW ;
Wyatt, WA ;
Silver, RT .
LEUKEMIA & LYMPHOMA, 1999, 34 (5-6) :481-+
[7]   Deletion of the multidrug resistance-associated protein (MRP1) gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impact [J].
Döhner, K ;
Schlenk, RF ;
van der Reijden, BA ;
Döhner, H .
LEUKEMIA, 2000, 14 (06) :1154-1154
[8]   Deletion size characterization of der(9) deletions in Philadelphia-positive chronic myeloid leukemia [J].
Douet-Guilbert, Nathalie ;
Morel, Frederic ;
Quemener, Sylvia ;
Maguer, Aurelie ;
Le Bris, Marie-Josee ;
Morice, Patrick ;
Berthou, Christian ;
De Braekeleer, Marc .
CANCER GENETICS AND CYTOGENETICS, 2006, 170 (02) :89-92
[9]   Deletion of BCR region 3′ in chronic myelogenous leukemia [J].
González, FA ;
Anguita, E ;
Mora, A ;
Asenjo, S ;
López, I ;
Polo, M ;
Villegas, A .
CANCER GENETICS AND CYTOGENETICS, 2001, 130 (01) :68-74
[10]   Thyroid hormone receptors/THR genes in human cancer [J].
González-Sancho, JM ;
García, V ;
Bonilla, M ;
Muñoz, A .
CANCER LETTERS, 2003, 192 (02) :121-132